FDA — authorised 17 May 1996
- Marketing authorisation holder: BIOGEN
- Status: approved
🇺🇸 Avonex in United States
FDA authorised Avonex on 17 May 1996
Marketing authorisations
FDA — authorised 23 February 2005
- Application: BLA103628
- Marketing authorisation holder: BIOGEN
- Indication: Labeling
- Status: approved
FDA — authorised 26 May 2020
- Application: BLA103780
- Marketing authorisation holder: SERONO INC
- Indication: Efficacy
- Status: approved
Avonex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Avonex approved in United States?
Yes. FDA authorised it on 17 May 1996; FDA authorised it on 23 February 2005; FDA authorised it on 26 May 2020.
Who is the marketing authorisation holder for Avonex in United States?
BIOGEN holds the US marketing authorisation.